MT-1 (Melanotan 1) 10mg

Description

Product Overview

Melanotan-1 (MT-1, Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2) is a synthetic tetradecapeptide supplied by PeptaCo for qualified laboratory research. It is a linear analog of α-melanocyte-stimulating hormone (α-MSH) with enhanced receptor binding affinity. Melanotan-1 is widely referenced in melanocortin receptor research and pigmentation studies.

Key Product Details

• Product Name: Melanotan-1 (MT-1)
• Specification: 10mg per vial
• Product Form: Lyophilized powder
• Category: Research Peptides — Melanocortin Agonist
• Peptide Length: 13 amino acids (acetylated N-terminus, amidated C-terminus)

Chemical Identity

Melanotan-1 is a linear tridecapeptide analog of α-MSH(4-13) with acetylation and amidation modifications. Molecular Formula: C₇₄H₉₄N₁₈O₁₄S. Molecular Weight: ~1646 Da. The modifications enhance metabolic stability compared to native α-MSH.

Research Context

Melanotan-1 is extensively studied in melanocortin research for its binding affinity at MC1-R (melanocortin 1 receptor). It is commonly referenced in investigations of pigmentation pathways, receptor pharmacology, and peptide structure-activity relationships. PeptaCo supplies Melanotan-1 in high-purity format for qualified laboratory customers.

Storage and Handling

Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.

Documentation and Quality

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.

Important Notice

This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.